MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway

Chemotherapy is important for adjuvant treatment of prostate cancer. However, some cancer cells exhibited low sensitivity to chemotherapeutic agents. We are supposed to sensitize these prostate cancer cells to chemotherapeutic agents such as doxorubicin. Previous reports have suggested that microRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Yan, Ren, Ligang, Xie, Bo, Liang, Zhen, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722564/
https://www.ncbi.nlm.nih.gov/pubmed/29228612
http://dx.doi.org/10.18632/oncotarget.21960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722564/
https://www.ncbi.nlm.nih.gov/pubmed/29228612
http://dx.doi.org/10.18632/oncotarget.21960

Ejemplares similares